Clinical Trial Update: CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 [Phase 1]

View source ↗

Summary

Phase 1 study update for KYV-101 (CARTIMMUNE) evaluating autoimmune diseases including idiopathic inflammatory myopathies, diffuse cutaneous systemic sclerosis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Diffuse Cutaneous Systemic Sclerosis
• Idiopathic Inflammatory Myopathies
• Lupus Nephritis

Drugs mentioned

• KYV-101

Snippet

Sponsor: David Porter | Conditions: Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis | Phase 1 | Status: ACTIVE_NOT_RECRUITING